Topic taxonomy suggestions experiment

Garadacimab (andembry) approved to prevent angioedema attacks

View document on GOV.UK (opens in new tab)

Existing topic taxonomy tags

Tags already associated with the document.

Suggested topic taxonomy tags

Tags which are used on similar documents.

Similar documents

The documents from which the suggested topic taxonomy tags are derived.

1. MHRA approves sebetralstat (Ekterly) to treat hereditary angioedema (HAE) attacks in patients aged 12 and over
2. MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP) 
3. Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors
4. MHRA approves teprotumumab as the first UK treatment for adults with moderate to severe Thyroid Eye Disease (TED)
5. Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B